Table 2

Predictors of HIV testing rates among eligible patients: meta-regression of results from studies identified

CovariateN studiesOR (95% CI)p Value
Patient group
 Patients presenting with indicator disease conditions100.8 (0.2 to 2.6)0.67
 Persons attending screening settings201 (ref)
Location of study
 London141 (ref)
 Non-London160.5 (0.2 to 1.6)0.26
Type of HIV test
 Laboratory71 (ref)
 Point-of-care60.8 (0.2 to 4)0.75
Service model*
 Usual practice181 (ref)
 Added staff training91.3 (0.4 to 4.8)0.62
 GUM specialist testing33.5 (0.5 to 24)0.2
Testing strategy
 Opt-out121 (ref)
 Opt-in91 (0.3 to 3.2)0.99
Study type
 Retrospective141 (ref)
 Prospective162.6 (0.9 to 7.7)0.08
  • *With only three studies in one of the categories, this result should be interpreted with caution due to lack of power.

  • GUM, genitourinary medicine.